Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M100,518Revenue (TTM) $M37,533Net Margin (%)3.3Altman Z-Score1.3
Enterprise Value $M120,402EPS (TTM) $0.2Operating Margin %9.3Piotroski F-Score5
P/E(ttm)86.3Beneish M-Score-2.4Pre-tax Margin (%)7.0Higher ROA y-yN
Price/Book71.610-y EBITDA Growth Rate %-1.7Quick Ratio0.6Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-8.2Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow19.4y-y EBITDA Growth Rate %-64.9ROA % (ttm)1.6Higher Current Ratio y-yN
Dividend Yield %5.1PEG--ROE % (ttm)46.7Less Shares Outstanding y-yN
Payout Ratio %1,429Shares Outstanding M4,872ROIC % (ttm)8.7Gross Margin Increase y-yY

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

GLAXF is held by these investors:

GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22-6.23view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14-2.41view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29289.98view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1271.92view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1447.36view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1271.92view

Quarterly/Annual Reports about GLAXF:

    News about GLAXF:

    Articles On GuruFocus.com
    If You Want Yield, Look to the UK Feb 19 2017 
    Flood of News Presents Buying Opportunity Jan 17 2017 
    Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
    GlaxoSmithKline, Vodafone Hit 3-Year Low Prices Dec 24 2016 
    Asset Sales, New Projects Fuel 6.7% Yield Dec 07 2016 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    Jeff Auxier Curbs Multiple Positions in 3rd Quarter Dec 01 2016 
    Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders Nov 28 2016 
    6 Worthy Dividend Stocks Down 10% or More Nov 22 2016 
    Kahn Brothers Adds to 4 Holdings in 3rd Quarter Nov 02 2016 

    More From Other Websites
    Could BP plc and GlaxoSmithKline plc help you retire early? Feb 17 2017
    GlaxoSmithKline’s Valuation Compared to Its Peers Feb 16 2017
    GlaxoSmithKline’s Consumer Healthcare Reports Growth in 4Q16 Feb 16 2017
    3 hot dividend stocks I’d buy in March Feb 16 2017
    British Blue Chips Snub Investor Calls to Show CEO Pay Ratio Feb 16 2017
    GlaxoSmithKline’s Vaccines Business Reported Growth in 4Q16 Feb 15 2017
    Gilead HIV Drug Tops GSK Combo, But Rivalry 'Intense' With GSK Doublet Feb 14 2017
    Performance of GlaxoSmithKline’s Pharmaceuticals Segment in 4Q16 Feb 14 2017
    4Q16 Performance of GlaxoSmithKline’s Business Segments Feb 14 2017
    GlaxoSmithKline PLC (ADR) (GSK) Two-Drug Cocktail Aims Decrease HIV Patient Pill Intake Feb 14 2017
    GlaxoSmithKline’s Revenue Trend for 4Q16 Feb 14 2017
    Gilead challenges GSK with strong HIV drug data Feb 14 2017
    Gilead challenges GSK with strong HIV drug data Feb 14 2017
    Gilead challenges GSK with strong HIV drug data Feb 14 2017
    PRESS DIGEST- Financial Times - Feb 14 Feb 13 2017
    [$$] GSK claims new HIV combination therapy will be 'less harmful' Feb 13 2017
    Can Gilead Swivel To HIV Amid Floundering Hep C Sales, GSK Rivalry? Feb 13 2017
    GlaxoSmithKline Plc :GLAXF-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017 Feb 13 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)